Grant to Help Coordinate Campaign to Train One Million Community Health Workers in sub-Saharan Africa

In an effort to broadly expand the reach of health care services in sub-Saharan Africa, GSK will contribute $750,000 to the One Million Community Health Workers Campaign.

Issued: London UK & Addis Ababa, Ethiopia

In an effort to broadly expand the reach of health care services in sub-Saharan Africa, GlaxoSmithKline (GSK) will contribute $750,000 to the One Million Community Health Workers Campaign.  Announced at the African Union Summit today, the funding will be used to create a new online “Operations Room” that will track the scale-up of community health workers and will serve as a central database of information for the Campaign, which is working with Ministries of Health in Africa to train, equip and deploy enough health workers to provide basic health care to millions of underserved people. By upgrading the quality and expanding the numbers of community health worker systems to provide national coverage, the Campaign hopes to help sub-Saharan African countries achieve the health-related Millennium Development Goals by 2015.

Duncan Learmouth, Senior Vice President, Developing Countries and Market Access, GSK said, “Trained community health workers are the backbone of the health system in Africa, providing essential services to the poorest communities. We are delighted to support this campaign and to further expand our commitment to improve access to healthcare in Africa. By generating valuable new information about the numbers, capability and quality of community health workers currently working in Africa, we can help support systems to deploy them most effectively and transform healthcare in rural areas.”

Community health workers have been recognized internationally for their success in reducing morbidity and averting mortality in mothers, newborns and children under 5. These workers are most effective when supported by a clinically skilled health workforce – particularly for child and maternal care – and deployed within the context of a basic primary healthcare system. They are also are crucial in settings where the overall primary healthcare system is weak and represent a strategic solution to address health worker shortages that make it difficult to meet growing demands for healthcare in rural areas.

“This generous grant from GlaxoSmithKline is key to scaling up Community Health Worker (CHW) systems across sub-Saharan Africa,” said Jeffrey Sachs, director of the Earth Institute and of the Sustainable Development Solutions Network. “Community health workers provide vital services to rural communities and GSK has been a pioneer and trail-blazer in the deployment of CHWs across Africa. The 1 Million Community Health Worker Campaign will save lives and help rural communities in sub-Saharan Africa to break free of extreme poverty.  By promoting the deployment of 1 million CHWs by 2015, roughly 1 per 100 households in rural areas, the campaign will support sub-Saharan Africa to make major strides towards the Millennium Development Goals."

The Operations Room will serve as a real-time dashboard of community health worker activities in sub-Saharan Africa: It will gather baseline data on where community health workers operate now, what training they have had and what services they provide. It will offer ongoing assessments of progress and best practices, and help countries speed up training and deployment of the workers. The Operations Room will help identify gaps in the systems and help national and local government agencies coordinate with UN agencies, private corporations and the many non-governmental organizations working on the continent.

GSK’s support for this campaign is part of a broad organizational commitment to invest in community health worker training. Since 2010, the company has re-invested 20 percent of any profits it makes in the world’s least developed countries back into training community health workers.  This will contribute to the training of 10,000 health workers over the next three years. Such programs exist so far in 26 sub-Saharan countries, delivered through partner NGOs, including Save the Children, AMREF, Care International and the Millennium Villages Project, a program of the Earth Institute.

This new grant from GSK will help create new roles to get the Operations Room up and running.  It will be located in Nairobi and Senegal in Africa in direct support of Ministries of Health as well as in New York, where the Earth Institute is based.

GlaxoSmithKline’s support will be directed to the UN Sustainable Development Solutions Network (SDSN), which is running the One Million Community Health Workers Campaign as part of its Solutions Initiative. The SDSN is overseen by a steering committee at the Earth Institute; Earth Institute Director Jeffrey Sachs is also director of the SDSN.

The One Million Community Health Worker Campaign is driven by the clear realization that success in achieving the health-related Millennium Development Goals requires the comprehensive expansion and upgrading of professionalized community health worker systems as part of national health strategies. The campaign was launched in January 2013 at the World Economic Forum in Davos and endorsed at the African Union Summit in Addis Ababa, with the support of African leaders, international organizations, regional networks and private sector partners.

For more information on the One Million Community Health Workers campaign, visit:

Press contacts: Erin Trowbridge,

· Follow the campaign on Facebook

· Follow the campaign blog

· Follow the campaign on Twitter

· Follow the campaign on Instagram

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit

GlaxoSmithKline Enquiries:


UK Media enquiries:

David Mawdsley

+44 (0) 20 8047 5502



Simon Steel

+44 (0) 20 8047 5502



David Daley

+44 (0) 20 8047 5502



Catherine Hartley

+44 (0) 20 8047 5502






US Media enquiries:

Stephen Rea

+1 215 751 4394



Kevin Colgan

+1 919 483 2933

(North Carolina)


Melinda Stubbee

+1 919 483 2510

(North Carolina)


Mary Anne Rhyne

+1 919 483 0492

(North Carolina)


Sarah Alspach

+1 202 715 1048

(Washington, DC)


Jennifer Armstrong

+1 215 751 5664




Analyst/Investor enquiries:

Ziba Shamsi

+ 44 (0) 20 8047 3289



Lucy Budd

+44 (0) 20 8047 2248



Tom Curry

+ 1 215 751 5419



Gary Davies

+ 44 (0) 20 8047 5503



James Dodwell

+ 44 (0) 20 8047 2406



Jeff McLaughlin

+ 1 215 751 7002


Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under Item 3.D 'Risk factors' in the company's Annual Report on Form 20-F for 2012.